41
Participants
Start Date
December 14, 2018
Primary Completion Date
February 27, 2019
Study Completion Date
February 27, 2019
Medium-fiber bar
Each subject will receive one control and two active treatments in a crossover design. The two active treatments are dietary fiber-containing bars at two doses of fiber. The control bar will not contain fiber.
High-fiber bar
Each subject will receive one control and two active treatments in a crossover design. The two active treatments are dietary fiber-containing bars at two doses of fiber. The control bar will not contain fiber.
Control bar (0 g fiber)
Each subject will receive one control and two active treatments in a crossover design. The two active treatments are dietary fiber-containing bars at two doses of fiber. The control bar will not contain fiber.
MB Clinical Research, Boca Raton
Great Lakes Clinical Trials, Chicago
Ingredion Incorporated
INDUSTRY
Midwest Center for Metabolic and Cardiovascular Research
OTHER